Back to Search Start Over

PET-BASED TREATMENT RESPONSE EVALUATION IN RECTAL CANCER: PREDICTION AND VALIDATION

Authors :
Janssen, Marco H. M.
Janssen, Marco H. M.
Ollers, Michel C.
van Stiphout, Ruud G. P. M.
Riedl, Robert G.
van den Bogaard, Jorgen
Buijsen, Jeroen
Lambin, Philippe
Lammering, Guido
Janssen, Marco H. M.
Janssen, Marco H. M.
Ollers, Michel C.
van Stiphout, Ruud G. P. M.
Riedl, Robert G.
van den Bogaard, Jorgen
Buijsen, Jeroen
Lambin, Philippe
Lammering, Guido
Source :
International Journal of Radiation Oncology Biology Physics vol.82 (2012) date: 2012-02-01 nr.2 p.871-876 [ISSN 0360-3016]
Publication Year :
2012

Abstract

Purpose: To develop a positron emission tomography (PET)-based response prediction model to differentiate pathological responders from nonresponders. The predictive strength of the model was validated in a second patient group, treated and imaged identical to the patients on which the predictive model was based. Methods and Materials: Fifty-one rectal cancer patients were prospectively included in this study. All patients underwent fluorodeoxyglucose (FDG) PET-computed tomography (CT) imaging both before the start of chemoradiotherapy (CRT) and after 2 weeks of treatment. Preoperative treatment with CRT was followed by a total mesorectal excision. From the resected specimen, the tumor regression grade (TRG) was scored according to the Mandard criteria. From one patient group (n = 30), the metabolic treatment response was correlated with the pathological treatment response, resulting in a receiver operating characteristic (ROC) curve based cutoff value for the reduction of maximum standardized uptake value (SUV(max)) within the tumor to differentiate pathological responders (TRG 1-2) from nonresponders (TRG 3-5). The applicability of the selected cutoff value for new patients was validated in a second patient group (n = 21). Results: When correlating the metabolic and pathological treatment response for the first patient group using ROC curve analysis (area under the curve = 0.98), a cutoff value of 48% SUV(max) reduction was selected to differentiate pathological responders from nonresponders (specificity of 100%, sensitivity of 64%). Applying this cutoff value to the second patient group resulted in a specificity and sensitivity of, respectively, 93% and 83%, with only one of the pathological nonresponders being false positively predicted as pathological responding. Conclusions: For rectal cancer, an accurate PET-based prediction of the pathological treatment response is feasible already after 2 weeks of CRT. The presented predictive model could be used to select p

Details

Database :
OAIster
Journal :
International Journal of Radiation Oncology Biology Physics vol.82 (2012) date: 2012-02-01 nr.2 p.871-876 [ISSN 0360-3016]
Notes :
DOI: 10.1016/j.ijrobp.2010.11.038, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1264550935
Document Type :
Electronic Resource